Latest news with #SequentScientific
Business Standard
6 days ago
- Business
- Business Standard
Sequent Scientific allots 30,000 equity shares under ESOP
Sequent Scientific has allotted 30,000 equity shares under ESOP on 26 June 2025. Consequent to the allotment of the aforesaid equity shares, the issued and the paid-up equity share capital of the Company will increase from Rs. 50,06,09,990 consisting of 25,03,04,995 equity shares of Rs. 2 each to Rs.50,06,69,990 consisting of 25,03,34,995 equity shares of Rs. 2 each. Powered by Capital Market - Live News
Business Standard
20-05-2025
- Business
- Business Standard
Sequent Scientific reports consolidated net profit of Rs 9.32 crore in the March 2025 quarter
Sales rise 11.21% to Rs 401.70 crore Net profit of Sequent Scientific reported to Rs 9.32 crore in the quarter ended March 2025 as against net loss of Rs 0.92 crore during the previous quarter ended March 2024. Sales rose 11.21% to Rs 401.70 crore in the quarter ended March 2025 as against Rs 361.20 crore during the previous quarter ended March 2024. For the full year,net profit reported to Rs 21.88 crore in the year ended March 2025 as against net loss of Rs 35.88 crore during the previous year ended March 2024. Sales rose 13.26% to Rs 1551.37 crore in the year ended March 2025 as against Rs 1369.73 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 401.70361.20 11 1551.371369.73 13 OPM % 11.518.93 - 10.434.48 - PBDT 32.7723.83 38 115.7324.28 377 PBT 16.657.35 127 49.28-37.26 LP NP 9.32-0.92 LP 21.88-35.88 LP
